Verve Therapeutics, Inc. logo VERV - Verve Therapeutics, Inc.

Inactive Ticker VERV is not actively trading. Quotes and analytics may be stale.
Price: -- --
Annual Quarterly
Metric 2025 Q1
Revenue
Revenue 33.0
Cost of Revenue 0
Gross Profit 33.0
Operating Expenses
R&D Expenses 54.5
SG&A Expenses 15.2
Other Expenses 0
Operating Expenses 69.6
Operating Income
Operating Income (36.6)
Interest Expense 0
Interest Income 5.5
Profitability
EBITDA (34.9)
EBIT (36.6)
Income Before Tax (31.0)
Income Tax Expense 0.1
Net Income (31.0)
Per Share Data
EPS (Basic) -0.35
EPS (Diluted) -0.35
Shares Outstanding 88.8
Metric 2025 Q1
Current Assets
Cash & Cash Equivalents 96.6
Short-Term Investments 400.5
Net Receivables 1.4
Inventory 0
Other Current Assets 13.2
Total Current Assets 511.6
Non-Current Assets
Property, Plant & Equipment 94.7
Goodwill 0
Intangible Assets 0
Long-Term Investments 0
Other Non-Current Assets 7.8
Total Non-Current Assets 102.5
Total Assets 614.2
Current Liabilities
Account Payables 5.4
Short-Term Debt 0
Deferred Revenue 19.1
Other Current Liabilities 7.0
Total Current Liabilities 52.0
Non-Current Liabilities
Long-Term Debt 0
Deferred Tax Liabilities 0
Other Non-Current Liabilities 1.0
Total Non-Current Liabilities 88.7
Total Liabilities 140.7
Stockholders' Equity
Common Stock 0.1
Retained Earnings (774.0)
Accumulated Other Comprehensive Income 0.4
Total Stockholders' Equity 473.5
Total Liabilities & Equity 614.2
Debt Metrics
Total Debt 68.6
Net Debt (27.9)
Metric 2025 Q1
Operating Activities
Net Income (31.0)
Depreciation & Amortization 1.7
Stock-Based Compensation 11.2
Change in Working Capital (9.5)
Other Non-Cash Items (0.3)
Operating Cash Flow (27.8)
Investing Activities
Capital Expenditure (1.2)
Acquisitions 0
Purchases of Investments (144.8)
Sales/Maturities of Investments 97.9
Other Investing Activities 0
Investing Cash Flow (48.2)
Financing Activities
Net Debt Issuance 0
Stock Repurchased 0
Dividends Paid 0
Other Financing Activities 0.0
Financing Cash Flow 0.0
Cash Position
Net Change in Cash (76.0)
Cash at Beginning 177.3
Cash at End 101.3
Free Cash Flow (29.1)
Key Metrics 2025 Q1
Income Statement
Revenue 33.0
Gross Profit 33.0
Operating Income (36.6)
Net Income (31.0)
EPS (Diluted) -0.35
Balance Sheet
Cash & Equivalents 96.6
Total Assets 614.2
Total Debt 68.6
Stockholders' Equity 473.5
Cash Flow
Operating Cash Flow (27.8)
Capital Expenditure (1.2)
Free Cash Flow (29.1)